udca

  1. forestglip

    Ursodeoxycholic Acid and Long COVID in Steatotic Liver Disease: A Nationwide Cohort Study, 2026, Jung et al

    Ursodeoxycholic Acid and Long COVID in Steatotic Liver Disease: A Nationwide Cohort Study Background/aims Ursodeoxycholic acid (UDCA) downregulates angiotensin-converting enzyme 2, the cellular entry receptor for SARS-CoV-2, and may reduce acute COVID-19 severity. However, it remains unknown...
  2. SNT Gatchaman

    Trial Report Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19, 2026, Lim et al.

    Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 BACKGROUND There is no proven treatment to alleviate symptoms of postacute sequelae of SARS-CoV-2 infection (PASC), despite its substantial public health burden. OBJECTIVE To evaluate the efficacy of...
Back
Top Bottom